✦ LIBER ✦

Cardiac catheterization in patients with end-stage liver disease: Safety and outcomes

✍ Scribed by Jayasree Pillarisetti; Pavan Patel; Sowjanya Duthuluru; Jenny Roberts; Warren Chen; Randall Genton; Mark Wiley; Robert Candipan; Peter Tadros; Kamal Gupta

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 58 KB
Volume: 77
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.22591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of invasive procedures in end-sta

Safety of invasive procedures in end-stage liver disease patients

✍ James D. Perkins 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Patients with end-stage liver disease (ESLD) are predisposed to bleeding complications due to thrombocytopenia, reduced synthesis of coagulation factors, and increased fibrinolytic activity. The exact incidence of vascular access site and bleeding complications related to cardiac catheterization in

Feasibility and safety of percutaneous c

Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation

✍ Babak Azarbal; Paul Poommipanit; Boris Arbit; Antoine Hage; Jignesh Patel; Miche 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Percutaneous coronary intervention (PCI) has traditionally not been an option for patients with end-stage liver disease (ESLD) and coronary artery disease (CAD). This retrospective study was designed to demonstrate the feasibility and safety of PCI in liver transplant candidates. Patients with ESLD

Low bleeding risk from cardiac catheteri

Low bleeding risk from cardiac catheterization in patients with advanced liver disease

✍ Paul T. Vaitkus; Carolyn Dickens; Mary Kay McGrath 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 1 views

Splanchnic hyperemia after liver transpl

Splanchnic hyperemia after liver transplantation in patients with end-stage liver disease

✍ Alvarez, Daniel ;Gerona, Solange ;Waisburg, Zulema ;Ciardullo, Miguel ;Santibañe 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 112 KB 👁 1 views

Systemic and splanchnic hemodynamic parameters were evaluated in 12 patients with cirrhosis before and 3 and 6 months after liver transplantation. Results were compared with those obtained in 8 healthy subjects. Three months after liver transplantation recipients had an increase in mean arterial pre

Sexual functioning in patients with end-

Sexual functioning in patients with end-stage liver disease before and after transplantation

✍ James H. Sorrell; Jill R. Brown 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The effects of end-stage liver disease (ESLD) on sexual functioning are complex and often overlooked in the context of chronic illness and the transplantation evaluation. The aim of the present study is to report on the prevalence of sexual dysfunction in patients with ESLD presenting for liver tran

Conivaptan increases serum sodium in hyp

Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease

✍ Jacqueline G. O'Leary; Gary L. Davis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Hyponatremia is associated with increased mortality in patients with end-stage liver disease and a greater risk of perioperative mortality with liver transplantation. We performed a retrospective review of our experience with conivaptan as a means of acutely increasing serum sodium in end-stage live